Lyra Therapeutics, Inc. (LYRA)
NASDAQ·Healthcare·Biotechnology
$0.55
-58.33%
Mkt Cap $2.31M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$0.50
Range $0.50 – $0.50
Implied Upside
-9.1%
Consensus $0.50 vs current $0.55
NASDAQ·Healthcare·Biotechnology
$0.55
-58.33%
Mkt Cap $2.31M
No recent rating data.
Price Target (1 analysts)
$0.50
Range $0.50 – $0.50
-9.1%
Consensus $0.50 vs current $0.55